<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36674238</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>13</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Long-Term Symptoms after Mild Coronavirus Disease in Healthy Healthcare Professionals: A 12-Month Prospective Cohort Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1483</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph20021483</ELocationID><Abstract><AbstractText>The coronavirus disease 2019 (COVID-19) pandemic has changed the course of human history and killed millions of people worldwide. Its long-term consequences remain uncertain. This study aimed to describe the short- and long-term symptoms of COVID-19 among individuals in Goi&#xe1;s, central Brazil, who experienced acute mild or non-symptomatic SARS-CoV-2 infection during the first wave of the pandemic. This prospective cohort study included 110 healthcare workers, 18 safety workers, and 19 administrative support workers, who were followed up for 12 months after the onset of COVID-19. Most participants were healthy adult female healthcare professionals. At the onset of infection, the major symptoms were headache, myalgia, nasal congestion, cough, coryza, anosmia, ageusia, sore throat, fatigue, diarrhea, and dyspnea. Furthermore, 20.3% of the participants had three or more COVID-19 symptoms that persisted for at least 12 months. These included coryza, congestion, hair loss, sore throat, headache, myalgia, cough, memory loss, anosmia, and fatigue. This study revealed a high prevalence of persistent symptoms of COVID-19 in healthy individuals from central Brazil, which may present an additional burden on healthcare services. Further studies are required to investigate the sequelae of COVID-19 over periods greater than 12 months.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>da Costa E Silva</LastName><ForeName>Grazielle Rosa</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Faculty of Nursing, Federal University of Goi&#xe1;s, Goi&#xe2;nia 74605-080, GO, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moura</LastName><ForeName>Winny &#xc9;veny Alves</ForeName><Initials>W&#xc9;A</Initials><Identifier Source="ORCID">0000-0002-6676-6573</Identifier><AffiliationInfo><Affiliation>Faculty of Nursing, Federal University of Goi&#xe1;s, Goi&#xe2;nia 74605-080, GO, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Santos</LastName><ForeName>Kamila Cardoso</ForeName><Initials>KC</Initials><Identifier Source="ORCID">0000-0001-9367-4837</Identifier><AffiliationInfo><Affiliation>Faculty of Nursing, Federal University of Goi&#xe1;s, Goi&#xe2;nia 74605-080, GO, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomes</LastName><ForeName>Davi Oliveira</ForeName><Initials>DO</Initials><AffiliationInfo><Affiliation>Faculty of Nursing, Federal University of Goi&#xe1;s, Goi&#xe2;nia 74605-080, GO, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bandeira</LastName><ForeName>Gabriela Nolasco</ForeName><Initials>GN</Initials><AffiliationInfo><Affiliation>Faculty of Nursing, Federal University of Goi&#xe1;s, Goi&#xe2;nia 74605-080, GO, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guimar&#xe3;es</LastName><ForeName>Rafael Alves</ForeName><Initials>RA</Initials><Identifier Source="ORCID">0000-0001-5171-7958</Identifier><AffiliationInfo><Affiliation>Faculty of Nursing, Federal University of Goi&#xe1;s, Goi&#xe2;nia 74605-080, GO, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosso</LastName><ForeName>Claci F&#xe1;tima Weirich</ForeName><Initials>CFW</Initials><AffiliationInfo><Affiliation>Faculty of Nursing, Federal University of Goi&#xe1;s, Goi&#xe2;nia 74605-080, GO, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bazilio</LastName><ForeName>Gabriela Silv&#xe9;rio</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Institute of Biological Science, Federal University of Goi&#xe1;s, Goi&#xe2;nia 74690-900, GO, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leite</LastName><ForeName>Vanessa Rafaela Milhomem Cruz</ForeName><Initials>VRMC</Initials><AffiliationInfo><Affiliation>Institute of Biological Science, Federal University of Goi&#xe1;s, Goi&#xe2;nia 74690-900, GO, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caetano</LastName><ForeName>Karlla Antonieta Amorim</ForeName><Initials>KAA</Initials><Identifier Source="ORCID">0000-0003-4818-4753</Identifier><AffiliationInfo><Affiliation>Faculty of Nursing, Federal University of Goi&#xe1;s, Goi&#xe2;nia 74605-080, GO, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carneiro</LastName><ForeName>Megmar Aparecida Dos Santos</ForeName><Initials>MADS</Initials><AffiliationInfo><Affiliation>Institute of Tropical Pathology and Public Health, Federal University of Goi&#xe1;s, Goi&#xe2;nia 74605-050, GO, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teles</LastName><ForeName>Sheila Ara&#xfa;jo</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0002-7059-4241</Identifier><AffiliationInfo><Affiliation>Faculty of Nursing, Federal University of Goi&#xe1;s, Goi&#xe2;nia 74605-080, GO, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063806" MajorTopicYN="N">Myalgia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086582" MajorTopicYN="N">Anosmia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010612" MajorTopicYN="Y">Pharyngitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">healthcare workers</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36674238</ArticleId><ArticleId IdType="pmc">PMC9865648</ArticleId><ArticleId IdType="doi">10.3390/ijerph20021483</ArticleId><ArticleId IdType="pii">ijerph20021483</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  WHO Coronavirus (COVID-19)  [(accessed on 2 June 2022)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Esakandari H., Nabi-Afjadi M., Fakkari-Afjadi J., Farahmandian N., Miresmaeili S.M., Bahreini E. A comprehensive review of COVID-19 characteristics. Biol. Proced. Online. 2020;22:19. doi: 10.1186/s12575-020-00128-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12575-020-00128-2</ArticleId><ArticleId IdType="pmc">PMC7402395</ArticleId><ArticleId IdType="pubmed">32774178</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochani R., Asad A., Yasmin F., Shaikh S., Khalid H., Batra S., Sohail M.R., Mahmood S.F., Ochani R., Arshad M.H., et al. COVID-19 pandemic: From origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management. Infez. Med. 2021;29:20&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">33664170</ArticleId></ArticleIdList></Reference><Reference><Citation>To K.K.-W., Sridhar S., Chiu K.H.-Y., Hung D.L.-L., Li X., Hung I.F.-N., Tam A.R., Chung T.W.-H., Chan J.F.-W., Zhang A.J.-X., et al. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerg. Microbes Infect. 2021;10:507&#x2013;535. doi: 10.1080/22221751.2021.1898291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1898291</ArticleId><ArticleId IdType="pmc">PMC8006950</ArticleId><ArticleId IdType="pubmed">33666147</ArticleId></ArticleIdList></Reference><Reference><Citation>Machhi J., Herskovitz J., Senan A.M., Dutta D., Nath B., Oleynikov M.D., Blomberg W.R., Meigs D.D., Hasan M., Patel M., et al. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J. Neuroimmune Pharm. 2020;15:359&#x2013;386. doi: 10.1007/s11481-020-09944-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-020-09944-5</ArticleId><ArticleId IdType="pmc">PMC7373339</ArticleId><ArticleId IdType="pubmed">32696264</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Kessel S.A.M., Olde Hartman T.C., Lucassen P.L.B.J., van Jaarsveld C.H.M. Post-acute and long-COVID-19 symptoms in patients with mild diseases: A systematic review. Fam. Pract. 2022;39:159&#x2013;167. doi: 10.1093/fampra/cmab076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavriatopoulou M., Korompoki E., Fotiou D., Ntanasis-Stathopoulos I., Psaltopoulou T., Kastritis E., Terpos E., Dimopoulos M.A. Organ-specific manifestations of COVID-19 infection. Clin. Exp. Med. 2020;20:493&#x2013;506. doi: 10.1007/s10238-020-00648-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-020-00648-x</ArticleId><ArticleId IdType="pmc">PMC7383117</ArticleId><ArticleId IdType="pubmed">32720223</ArticleId></ArticleIdList></Reference><Reference><Citation>Asselah T., Durantel D., Pasmant E., Lau G., Schinazi R.F. COVID-19: Discovery, diagnostics and drug development. J. Hepatol. 2021;74:168&#x2013;184. doi: 10.1016/j.jhep.2020.09.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.09.031</ArticleId><ArticleId IdType="pmc">PMC7543767</ArticleId><ArticleId IdType="pubmed">33038433</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn D.-G., Shin H.-J., Kim M.-H., Lee S., Kim H.-S., Myoung J., Kim B.-T., Kim S.-J. Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19) J. Microbiol. Biotechnol. 2020;30:313&#x2013;324. doi: 10.4014/jmb.2003.03011.</Citation><ArticleIdList><ArticleId IdType="doi">10.4014/jmb.2003.03011</ArticleId><ArticleId IdType="pmc">PMC9728410</ArticleId><ArticleId IdType="pubmed">32238757</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., Bobkova P., Spiridonova E., Shikhaleva A., Gamirova A., Blyuss O., Nekliudov N., Bugaeva P., Andreeva M., DunnGalvin A., et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin. Exp. Allergy. 2021;51:1107&#x2013;1120. doi: 10.1111/cea.13997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13997</ArticleId><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention  COVID-19&#x2013;Long COVID. Centers for Disease Control and Prevention. Updated 1 September 2022.  [(accessed on 28 November 2022)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>Desai A.D., Lavelle M., Boursiquot B.C., Wan E.Y. Long-term complications of COVID-19. Am. J. Physiol. Cell Physiol. 2022;322:1&#x2013;11. doi: 10.1152/ajpcell.00375.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayo Foundation for Medical Education and Research  COVID-19: Long-Term Effects.  [(accessed on 9 November 2022)].  Available online:  https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/coronavirus-long-term-effects/art-20490351/</Citation></Reference><Reference><Citation>Rodriguez-Morales A.J., Cardona-Ospina J.A., Guti&#xe9;rrez-Ocampo E., Villamizar-Pe&#xf1;a R., Houlguin-Rivera Y., Escalera-Antezana J.P., Alvarado-Arnez L.E., Bonilda-Aldana D.K., Franco-Paredes C., Henao-Martinez A.F., et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med. Infect. Dis. 2020;34:101623. doi: 10.1016/j.tmaid.2020.101623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2020.101623</ArticleId><ArticleId IdType="pmc">PMC7102608</ArticleId><ArticleId IdType="pubmed">32179124</ArticleId></ArticleIdList></Reference><Reference><Citation>Meo S.A., Meo A.S., Al-Jassir F.F., Klonoff D.C. Omicron SARS-CoV-2 new variant: Global prevalence and biological and clinical characteristics. Eur. Rev. Med. Pharm. Sci. 2021;25:8012&#x2013;8018. doi: 10.26355/eurrev_202112_27652.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202112_27652</ArticleId><ArticleId IdType="pubmed">34982465</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshee S., Vatti N., Chang C. Long-term effects of COVID-19. Mayo Clin. Proc. 2022;97:579&#x2013;599. doi: 10.1016/j.mayocp.2021.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.12.017</ArticleId><ArticleId IdType="pmc">PMC8752286</ArticleId><ArticleId IdType="pubmed">35246288</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonif&#xe1;cio L.P., Csizmar V.N.F., Barbosa-J&#xfa;nior F., Pereira A.P.S., Koenigkam-Santos M., Wada D.T., Gaspar G., Carvalho F.S., Bollela V.R., Santana R.C., et al. Long-term symptoms among COVID-19 survivors in prospective cohort study, Brazil. Emerg. Infect. Dis. 2022;28:730&#x2013;733. doi: 10.3201/eid2803.212020.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2803.212020</ArticleId><ArticleId IdType="pmc">PMC8888217</ArticleId><ArticleId IdType="pubmed">35133956</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Palacios-Ce&#xf1;a D., Florencio L.L., Guerrero A.L., Garc&#xed;a-Azor&#xed;n D., Hern&#xe1;ndez-Barrera V., Arendt-Nielsen L. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study. Cephalalgia. 2021;41:1332&#x2013;1341. doi: 10.1177/03331024211020404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024211020404</ArticleId><ArticleId IdType="pmc">PMC8212025</ArticleId><ArticleId IdType="pubmed">34134526</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ca&#xf1;as C.A. The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals. Med. Hypotheses. 2020;145:110345. doi: 10.1016/j.mehy.2020.110345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110345</ArticleId><ArticleId IdType="pmc">PMC7556280</ArticleId><ArticleId IdType="pubmed">33080459</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deveau T.M., Munter S.E., Ryder D., Buck A., Lu S., Goldberg S.A., Hoh R., Tai V., Torres L., et al. Impact of pre-existing chronic viral infection and reactivation on the development of long COVID. MedRxiv. 2022:e163669. doi: 10.1172/JCI163669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI163669</ArticleId><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M., Soddu D., Balbo P.E., Baricich A., Zeppegno P., Avanzi G.C., Baldon G., Bartolomei G., Battaglia M., Battistini S., et al. Respiratory and Psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA. 2021;4:e2036142. doi: 10.1001/jamanetworkopen.2020.36142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.36142</ArticleId><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long Covid: An overview. Diab. Met. Syndr. Clin. Res. Rev. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC9637465</ArticleId><ArticleId IdType="pubmed">36351871</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin L.B., Weinstock L.B., Molderings G.J. COVID-19 hyperinflammation and post-COVID-19 illness may be rooted in mast cell activation syndrome. Int. J. Infect. Dis. 2020;100:327&#x2013;332. doi: 10.1016/j.ijid.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Coomes E.A., Haghbayan H. Interleukin-6 in COVID-19: A systematic review and meta-analysis. Rev. Med. Virol. 2020;30:1&#x2013;9. doi: 10.1002/rmv.2141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2141</ArticleId><ArticleId IdType="pmc">PMC7460877</ArticleId><ArticleId IdType="pubmed">32845568</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharifkashani S., Bafrani M.A., Khaboushan A.S., Pirzadeh M., Kheirandish A., Yavarpour_Bali H., Hessami A., Saghazadeh A., Rezaei N. Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting. Eur. J. Pharm. 2020;884:173455. doi: 10.1016/j.ejphar.2020.173455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2020.173455</ArticleId><ArticleId IdType="pmc">PMC7834210</ArticleId><ArticleId IdType="pubmed">32745604</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., Laue M., Schneider J., Br&#xfc;nink S., Greuel S., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2021;24:168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen B., Tosti A. Alopecia in patients with COVID-19: A systematic review and meta-analysis. JAAD Int. 2022;7:67&#x2013;77. doi: 10.1016/j.jdin.2022.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdin.2022.02.006</ArticleId><ArticleId IdType="pmc">PMC8860672</ArticleId><ArticleId IdType="pubmed">35224518</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Li X., Geng D., Mei N., Wu P.-Y., Huang C.-C., Jia T., Zhao Y., Wang D., Xiao A., et al. Cerebral micro-structural changes in COVID-19 patients&#x2013;an MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25:100484. doi: 10.1016/j.eclinm.2020.100484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100484</ArticleId><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Siemieniuk R.A., Bartoszko J.J., Ge L., Zeraatkar D., Izcovich A., Kum E., Pardo-Hernandez H., Qasim A., Martinez J.P.D., Rochwerg B., et al. Drug treatments for covid-19: Living systematic review and network meta-analysis. BMJ. 2020;370:2980. doi: 10.1136/bmj.m2980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2980</ArticleId><ArticleId IdType="pmc">PMC7390912</ArticleId><ArticleId IdType="pubmed">32732190</ArticleId></ArticleIdList></Reference><Reference><Citation>Boschiero M.N., Palamim C.V.C., Ortega M.M., Mauch R.M., Marson F.A.L. One year of coronavirus disease 2019 (COVID-19) in Brazil: A political and social overview. Ann. Glob. Health. 2021;87:1&#x2013;27. doi: 10.5334/aogh.3182.</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/aogh.3182</ArticleId><ArticleId IdType="pmc">PMC8139306</ArticleId><ArticleId IdType="pubmed">34046307</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanni S.E., Bacha H.A., Naime A., Bernardo W.M. Use of hydroxychloroquine to prevent SARS-CoV-2 infection and treat mild COVID-19: A systematic review and meta-analysis. J. Bras. Pneumol. 2021;47:e20210236. doi: 10.36416/1806-3756/e20210236.</Citation><ArticleIdList><ArticleId IdType="doi">10.36416/1806-3756/e20210236</ArticleId><ArticleId IdType="pmc">PMC9013536</ArticleId><ArticleId IdType="pubmed">34669839</ArticleId></ArticleIdList></Reference><Reference><Citation>Younis N.K., Zareef R.O., Hassan S.N.A., Bitar F., Eid A.H., Arabi M. Hidroxychloroquine in COVID-19 patients: Pros and cons. Front. Pharm. 2020;11:1&#x2013;16. doi: 10.3389/fphar.2020.597985.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.597985</ArticleId><ArticleId IdType="pmc">PMC7751757</ArticleId><ArticleId IdType="pubmed">33364965</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho T.-C., Wang Y.-H., Chen Y.-L., Tsai W.-C., Lee C.-H., Chuang K.-P., Chen Y.-M., Yuan C.-H., Ho S.-Y., Yang M.-H., et al. Chloroquine and Hydroxycholoroquine: Efficacy in the treatment of the COVID-19. Pathogens. 2021;10:217. doi: 10.3390/pathogens10020217.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10020217</ArticleId><ArticleId IdType="pmc">PMC7922580</ArticleId><ArticleId IdType="pubmed">33671315</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>